Ksenia Blinova | Pharmacology | Best Researcher Award

Dr. Ksenia Blinova | Pharmacology | Best Researcher Award

Associate Director at US Food and Drug Administration, United States

Dr. Ksenia Blinova, Ph.D., is the Associate Director for the Division of Applied Regulatory Science at the U.S. Food and Drug Administration, where she leads innovative research, regulatory reviews, and scientific consultations that advance translational science in support of public health. With a strong academic foundation in physics, mathematics, and cardiac electrophysiology, she has built a distinguished career focused on bridging fundamental science with regulatory applications. Since joining the FDA as a Commissioner’s Fellow, Dr. Blinova has held key leadership roles, including Deputy Director of the Division of Biomedical Physics, where she led multidisciplinary teams in developing over forty regulatory science tools that improved the evaluation of medical devices across fields such as cardiology, neurostimulation, diagnostics, and patient monitoring. Her career reflects a unique combination of scientific excellence, leadership, and commitment to advancing safe and effective medical products, making her an influential figure in the field of regulatory science.

Professional Profile 

Scopus Profile | ORCID Profile 

Education

Dr. Ksenia Blinova earned her undergraduate and doctoral degrees in Physics and Mathematics from Moscow State University, where she developed a strong foundation in quantitative sciences and analytical problem-solving. She further advanced her academic journey through a postdoctoral fellowship at the National Heart, Lung, and Blood Institute at the National Institutes of Health. Her research during this period centered on cardiac electrophysiology and metabolism, areas that deepened her expertise in biomedical applications of physical sciences. This educational trajectory not only equipped her with advanced technical knowledge but also gave her a unique interdisciplinary perspective that integrates rigorous physics and mathematical methodologies with life sciences and clinical research. Her educational background has been pivotal in shaping her ability to address complex regulatory and scientific challenges, contributing to her capacity for innovation and leadership in translational science and regulatory policy at the intersection of medicine, technology, and public health.

Experience

Dr. Blinova has built a distinguished career at the U.S. Food and Drug Administration, beginning as a Commissioner’s Fellow and progressing to influential leadership roles. As Deputy Director of the Division of Biomedical Physics in the Center for Devices and Radiological Health, she guided a multidisciplinary team in creating innovative regulatory science tools that addressed critical challenges in medical device safety and effectiveness. Her leadership was instrumental in developing methods and resources for fields such as cardiology, neurostimulation, ophthalmology, in-vivo diagnostics, and advanced patient monitoring. Currently serving as Associate Director for the Division of Applied Regulatory Science in the Office of Clinical Pharmacology, she oversees research, scientific consultations, and regulatory reviews that support the FDA’s translational science priorities. Through these roles, she has combined her technical expertise with strategic vision, ensuring that scientific advancements translate into practical regulatory applications that safeguard patient health and promote medical innovation.

Research Focus

Dr. Blinova’s research focuses on advancing translational and regulatory science to accelerate the safe and effective delivery of medical products to patients. Her early work in cardiac electrophysiology and metabolism provided insights into fundamental mechanisms of heart function, laying the groundwork for her later contributions in biomedical physics and device evaluation. At the FDA, she has led research efforts that integrate computational modeling, experimental studies, and regulatory tool development to address complex safety and efficacy challenges in medical devices and drug-device combinations. Her team has developed innovative approaches to evaluate technologies in cardiology, neurostimulation, electrical safety, diagnostics, and patient monitoring, ensuring that regulatory science keeps pace with rapid technological advances. By bridging basic science, applied research, and policy, her work exemplifies the role of regulatory science in translating innovation into tangible benefits for patients and healthcare systems, while maintaining a focus on safety, effectiveness, and public health impact.

Award and Honor

Throughout her career, Dr. Blinova has been recognized for her leadership, innovation, and contributions to regulatory science. Her accomplishments include guiding the development of over forty regulatory tools that have had a lasting impact on how medical devices are assessed for safety and effectiveness. These achievements reflect not only her scientific expertise but also her ability to collaborate across disciplines to solve pressing healthcare challenges. Her recognition within the FDA and broader scientific community underscores her role as a leader who consistently advances the field of translational science. Honors and awards in her career highlight her success in bridging science and regulation, her dedication to patient safety, and her influence in shaping modern approaches to medical product evaluation. These distinctions serve as a testament to her sustained contributions, her commitment to innovation, and her growing impact as a respected figure in regulatory and biomedical research.

Publication Top Notes

  • Title: Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential
    Authors: M. Iveth Garcia, Bhavya Bhardwaj, Keri Dame, Verena Charwat, Brian A. Siemons, Ishan Goswami, Omnia A. Ismaiel, Sabyasachy Mistry, Tromondae K. Feaster, Kevin E. Healy, et al.
    Year: 2025

  • Title: In Vitro Assay Development to Study Pulse Field Ablation Outcome Using Solanum Tuberosum
    Authors: Akshay Narkar, Abouzar Kaboudian, Yasaman Ardeshirpour, Maura Casciola, Tromondae Feaster, Ksenia Blinova
    Year: 2024
    Citations: 2

  • Title: Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues
    Authors: Tromondae K. Feaster, Jourdan K. Ewoldt, Anna Avila, Maura Casciola, Akshay Narkar, Christopher S. Chen, Ksenia Blinova
    Year: 2024

  • Title: Comprehensive Collection of Current Methods for Contractility and Electrophysiology Recordings in Human Cardiac Cells
    Authors: Ksenia Blinova, J. Pierson, A. Narkar
    Year: 2023

  • Title: Human in vitro assay for irreversible electroporation cardiac ablation
    Authors: Maura Casciola, Tromondae K. Feaster, M. J. Caiola, D. Keck, Ksenia Blinova
    Year: 2023

  • Title: Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
    Authors: Tromondae K. Feaster, N. Feric, I. Pallotta, A. Narkar, M. Casciola, M. P. Graziano, R. Aschar-Sobbi, Ksenia Blinova
    Year: 2022

  • Title: Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2022

  • Title: Human in vitro neurocardiac coculture (iv NCC) assay development for evaluating cardiac contractility modulation
    Authors: Akshay Narkar, Tromondae K. Feaster, Maura Casciola, Ksenia Blinova
    Year: 2022

  • Title: Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
    Authors: Maura Casciola, Devin Keck, Tromondae K. Feaster, Ksenia Blinova
    Year: 2022

  • Title: Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Authors: Akshay Narkar, James M. Willard, Ksenia Blinova
    Year: 2022

  • Title: Cardiovascular medical devices: Regulatory science research overview in the office of science and engineering laboratories (OSEL) at the food and drug administration (FDA)
    Authors: K. Aycock, Ksenia Blinova, M. Casciola, B. Craven, M. Di Prima, G. D’Souza, N. Duraiswamy, M. Farahmand, P. Hariharan, L. Herbertson, et al.
    Year: 2021

  • Title: Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2021

Conclusion

Dr. Ksenia Blinova has demonstrated exceptional expertise and leadership in translational and regulatory science, particularly in the evaluation and development of cardiac therapies and medical devices. Her extensive body of research, including numerous high-impact publications on human in vitro cardiac models, contractility modulation, and electroporation assays, reflects a consistent focus on innovative approaches that bridge fundamental science with practical clinical and regulatory applications. She has led multidisciplinary teams to develop tools and methodologies that enhance patient safety, accelerate medical innovation, and provide reliable scientific evidence for regulatory decisions. Her work not only advances the understanding of cardiac electrophysiology and device performance but also sets new standards for predictive, nonclinical cardiac research. Overall, Dr. Blinova’s contributions exemplify the qualities of a pioneering researcher whose scientific rigor, leadership, and commitment to public health make her highly deserving of recognition in any Best Researcher Award.

Angelica Rachel Carpio | Pharmacology | Best Researcher Award

Ms. Angelica Rachel Carpio | Pharmacology | Best Researcher Award

Ms. Angelica Rachel Carpio at DLSU Laguna, Philippines

Angelica Rachel E. Carpio is a highly driven bioengineer and nanotechnology researcher from Mapúa University, where she is completing both her Bachelor’s and Master’s degrees in Biological Engineering. With published research in respected journals such as Life and the Journal of the Taiwan Institute of Chemical Engineers, her work explores innovative applications of natural compounds and nanomaterials for therapeutic use. She has hands-on experience in advanced laboratory techniques, computational modeling, and scientific writing, strengthened by international research training in Taiwan and immersion in Japan. Currently, she contributes to nanotechnology development at De La Salle University, focusing on photoluminescent inks using carbon nanodots. In addition to her technical expertise, Angelica has held leadership roles in various academic organizations, showcasing her teamwork and communication skills. Her multidisciplinary approach, academic excellence, and commitment to scientific advancement make her a promising and impactful researcher in the field of bioengineering and nanotechnology.

Professional Profile 

Scopus Profile

Education

Angelica Rachel E. Carpio is currently pursuing a dual degree program—Bachelor and Master of Science in Biological Engineering—at Mapúa University in Manila, Philippines, from 2020 to 2025. Her academic journey reflects consistent excellence, having previously completed the Science, Technology, Engineering, and Mathematics (STEM) strand during her senior high school years at the same university. Throughout her education, Angelica has been recognized for her academic performance, earning quarterly and semestral honors. Her foundational years at St. Mary’s Academy of Caloocan City also demonstrate early academic strength. Her coursework blends bioengineering, nanotechnology, and computational sciences, preparing her for interdisciplinary research. Her involvement in technical and laboratory-intensive education has equipped her with both theoretical knowledge and practical skills, making her a well-rounded scholar capable of tackling complex scientific challenges across engineering and life sciences.

Professional Experience

Angelica Rachel E. Carpio has gained practical research and academic experience in multiple capacities across institutions. As of March 2025, she serves as a Project Technical Assistant I at De La Salle University’s Center for Natural Sciences and Environmental Research, where she is actively involved in nanotechnology research, particularly the development of photoluminescent inks using carbon nanodots. Previously, she completed a research internship at National I-lan University in Taiwan, contributing to projects in biochemistry and microbial fuel cells, which culminated in a scholarly publication. Her earlier experience includes a role as a Student Assistant at Mapúa University, where she facilitated administrative tasks and student outreach. She also participated in a scientific immersion program in Tokyo, Japan, expanding her global perspective. These diverse roles reflect a well-rounded professional background that combines scientific inquiry, technical execution, and organizational support, laying a strong foundation for a research-intensive career.

Research Interest

Angelica’s research interests are rooted in the intersection of bioengineering, nanotechnology, and computational biology. She focuses on developing therapeutic strategies using natural products, such as plant metabolites and microbial fermentation, combined with modern molecular techniques. Her recent publications explore the anti-cancer potential of Vaccinium-derived compounds and the enhanced production of anthraquinones in rhubarb through fermentation, showcasing her inclination toward pharmacological innovation using bioinformatics tools like molecular docking and network analysis. She is also engaged in nanomaterial research, particularly in developing carbon-based nanodots for photoluminescent applications, revealing a keen interest in functional biomaterials. Her ability to integrate wet-lab experiments with computational modeling highlights a strong systems-level approach to research. This multidimensional interest positions her at the forefront of modern biological engineering, where she aims to bridge natural sciences with engineered solutions for health and environmental applications.

Award and Honor

Angelica Rachel Carpio has consistently earned recognition for her academic and leadership excellence throughout her educational journey. She has received quarterly and semestral academic excellence awards during her time in senior high school at Mapúa University, where she graduated with honors. At St. Mary’s Academy of Caloocan City, she was also an Academic Excellence Awardee, underscoring her consistent performance from an early age. While specific research awards are not listed, her publications in reputable international journals, her international research internship in Taiwan, and participation in a scientific immersion in Japan stand as strong indicators of merit. Furthermore, her selection as a Project Technical Assistant I at a prominent research center such as De La Salle University is, in itself, a form of professional recognition. These accomplishments reflect both academic rigor and early research impact, validating her potential as a high-achieving scholar and future leader in scientific research.

Conclusion

Angelica Rachel E. Carpio emerges as a promising and multifaceted researcher with a solid educational background, hands-on professional experience, and a clear focus on innovation at the intersection of nanotechnology and biological engineering. Her early contributions to research through published work, international exposure, and technical roles at prestigious institutions showcase her ability to apply scientific knowledge to real-world problems. Angelica’s diverse skill set—from laboratory techniques and computational modeling to leadership in academic organizations—demonstrates maturity beyond her years. She represents the new generation of researchers who are collaborative, globally aware, and technically adept. With continued mentorship and opportunities to expand her research portfolio, Angelica is well on track to make meaningful contributions to the scientific community. Her credentials make her an excellent candidate for honors such as the Best Researcher Award, especially in the category of emerging or early-career researchers.

Publications Top Notes

  • Title: Berries as Nature’s Therapeutics: Exploring the Potential of Vaccinium Metabolites in Gastric Cancer Treatment Through Computational Insights
    Authors: Carpio, Angelica Rachel; Talubo, Nicholas Dale D.; Tsai, Po Wei; Chen, Boryann; Tayo, Lemmuel Lara
    Year: 2025
    Journal: Life